List Of Publications

K. Dáňová, A. Klapetková, J. Kayserová, A. Šedivá, R. Špíšek, L.P. Jelínková

NF-κB, p38 MAPK, ERK1/2, mTOR, STAT3 and increased glycolysis regulate stability of paricalcitol/dexamethasone-generated tolerogenic dendritic cells in the inflammatory environment.

Oncotarget. 2015 Jun 10;6(16):14123-38.

M. Podrazil, R. Horváth, E. Becht, D. Rožková, P. Bílková, K. Sochorová, H. Hromádková, J. Kayserová, K. Vávrová, J. Laštovička, P. Vrabcová, K. Kubacková, Z. Gasová, L. Jarolim, M. Babjuk, R. Śpíšek, J. Bartůňková, J. Fučíková

Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer.

Oncotarget. 2015 May 29. [Epub ahead of print]

F. Aranda, A. Buqué, N. Bloy, F. Castoldi, A. Eggermont, I. Cremer, W.H. Fridman, J. Fučíková, J. Galon, R. Špíšek, E. Tartour, L. Zitvogel, G. Kroemer, L. Galluzzi

Trial Watch: Adoptive cell transfer for oncological indications.

Oncoimmunology. 2015 May 5;4(11):e1046673. eCollection 2015 Nov. Review.
This website uses cookies; by continuing to use this page, you consent to their use. About cookies